A Novel Protein NAB1‐356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis
Advanced Science · 2025-05 · 12 (20)
DOI: 10.1002/advs.202411959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.03.2025. Verfasst von William W Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sunnybrook Research Institute, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, M4N3M5, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, RNA, Circular, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Atrial fibrillation (AF) is a common arrhythmia with irregular atrial electrical activity. Circular RNAs (circRNAs) are key regulators in tissue homeostasis, yet their role in AF remains unclear. Here, we investigated the expression and function of circNAB1 in AF using high‐throughput sequencing and functional assays in circNAB1 transgenic mice. We identified circNAB1 as a significantly downregulated circRNA in AF patient specimens. Silencing circNAB1 promoted collagen deposition and inflammation, whereas overexpression reduces atrial fibrosis and AF susceptibility in mice, consistent with results observed in human atrial tissues. Mechanistically, circNAB1 translates into a novel protein, NAB1‐356, which is highly expressed in human cardiac hypertrophy. NAB1‐356 interacts with EGR1 as NAB1 does, decreasing fibrosis and inflammation in the atrium. Furthermore, NAB1‐356 also regulates transcription factor Runx1 and Gadd45b transcription, exerting regulatory effects on cytokine expression and fibrosis. Targeting EGR1, Gadd45b, and Runx1 by circNAB1 or siRNAs attenuate AF incidence and cardiac remodeling, suggesting potential therapeutic strategies for AF management. Delivery of circNAB1 improves AF conditions in LKB1 knockout mice, further highlighting its anti‐arrhythmic potential. Our findings elucidate the mechanistic role of circNAB1 in AF pathogenesis and suggest its therapeutic implications for cardiac remodeling‐associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sunnybrook Research Institute, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, M4N3M5, Canada.
- Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
- Toronto General Research Institute, University Health Network, Department of Physiology, University of Toronto, Toronto, M5G 2C4, Canada.
- Department of Anesthesiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, China.
ORCID-Profile: Burton B Yang
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Du, W. W., Rafiq, M., Yuan, H., Li, X., Wang, S., Wu, J., Wei, J., Li, R. K., Guo, H., & Yang, B. B. (2025). A Novel Protein NAB1‐356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis. Advanced Science, 12(20). https://doi.org/10.1002/advs.202411959
Vancouver
Du WW, Rafiq M, Yuan H, Li X, Wang S, Wu J, et al. A Novel Protein NAB1‐356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis. Advanced Science. 2025;12(20). doi:10.1002/advs.202411959
BibTeX
@article{Du2025,
author = {Du, William W and Rafiq, Muhammad and Yuan, Hui and Li, Xiangmin and Wang, Sheng and Wu, Jun and Wei, Jinfeng and Li, Ren-Ke and Guo, Huiming and Yang, Burton B},
title = {A Novel Protein NAB1‐356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {20},
doi = {10.1002/advs.202411959}
}
EUVIMED